Hmgene, Inc.

Piscataway, NJ 08854

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $836K
First Award Date 08/15/99
Most Recent Award Date 09/01/02

Key Personnel

Last Name Name Awards Contact
Chouinard Roland A Chouinard 4

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/02 - 02/29/04

DESCRIPTION (provided by applicant): Colon cancer is a major health concern of the United States, with an estimated 129,400 new cases reported in 1999. Colon cancer is now the second leading cancer killer of both men and women in the U.S. after lung cancer. The successful management of this disease will require the discovery of safe and effecti...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/01 - 07/31/03

The unique, novel approach of HMGene to obesity treatment is to develop drugs that act directly on adipose tissue. The goal of Phase II will be to further validate HMGI-C, an architectural transcription factor which regulates gene expression in adipogenesis, as a drug target in obesity. In Phase I, it was shown that inactivation of HMGI-C revers...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/00 - 07/30/01

The unique, novel approach of HMGene to obesity treatment is to develop drugs that act directly on adipose tissue. The goal of Phase II will be to further validate HMGI-C, an architectural transcription factor which regulates gene expression in adipogenesis, as a drug target in obesity. In Phase I, it was shown that inactivation of HMGI-C revers...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/99 - 08/14/00

DESCRIPTION (Adapted from the application): It is proposed in this application to test whether the DNA binding protein HMGI-C is involved in the development of obesity in the ob/ob mouse. This will be accomplished by breeding ob/ob mice in which one or both HMGI-C alleles have been disrupted, and assessing the impact ...